Back
CBRE Global Real Estate Income Fund Vs. Guardant Health, Inc. Industry Stock Comparison
Sell
41
IGR
CBRE Global Real Estate Income Fund
Last Price:
$4.30
Seasonality Move:
-0.18%
Buy
55
GH
Guardant Health, Inc.
Last Price:
$102.45
Seasonality Move:
12.83%
Sell
41
CBRE Global Real Estate Income Fund (IGR)
is a Sell
Is CBRE Global Real Estate Income Fund a Buy, Sell or Hold?
-
The current CBRE Global Real Estate Income Fund [IGR] share price is $4.30. The Score for IGR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
IGR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Guardant Health, Inc. (GH)
is a Buy
Is Guardant Health, Inc. a Buy, Sell or Hold?
-
The current Guardant Health, Inc. [GH] share price is $102.38. The Score for GH is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
GH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IGR Stock Price Chart
What is CBRE Global Real Estate Income Fund's stock price today?
-
The CBRE Global Real Estate Income Fund share price today is $4.30The current trend is relatively stagnant and IGR is experiencing buying pressure, which is a positive indicator for future bullish movement.
GH Stock Price Chart
What is Guardant Health, Inc.'s stock price today?
-
The Guardant Health, Inc. share price today is $102.38Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GH is experiencing slight buying pressure.
IGR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 38.6 | Sell |
| Chaikin Money Flow: | 627909 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.28 - 4.6) | Sell |
| Bollinger Bands (100): | (4.58 - 5.12) | Sell |
GH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.49 | Buy |
| Relative Strength Index (14 RSI): | 55.78 | Buy |
| Chaikin Money Flow: | 133567 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (99.8 - 106.9) | Sell |
| Bollinger Bands (100): | (56.78 - 96.6) | Buy |
IGR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.29 | Buy |
| 20-day SMA: | 4.4 | Sell |
| 50-day SMA: | 4.67 | Sell |
| 200-day SMA: | 4.95 | Sell |
| 8-day EMA: | 4.31 | Sell |
| 20-day EMA: | 4.4 | Sell |
| 50-day EMA: | 4.52 | Sell |
| 200-day EMA: | 3.08 | Buy |
GH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 100.4 | Buy |
| 20-day SMA: | 102.92 | Sell |
| 50-day SMA: | 93.71 | Buy |
| 200-day SMA: | 60.95 | Buy |
| 8-day EMA: | 101.24 | Buy |
| 20-day EMA: | 100.96 | Buy |
| 50-day EMA: | 93.26 | Buy |
| 200-day EMA: | 66.89 | Buy |
CBRE Global Real Estate Income Fund Earnings Growth & IGR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Guardant Health, Inc. Earnings Growth & GH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.36 per share.
CBRE Global Real Estate Income Fund Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Guardant Health, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||